Ticker Details
Larimar Therapeutics, Inc. Common Stock
IPO Date:	July 1, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$429.04M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 4.90%
Avg Daily Range (30 D):	$0.17 | 4.63%
Avg Daily Range (90 D):	$0.17 | 4.05%

Institutional Daily Volume
Avg Daily Volume:	.32M
Avg Daily Volume (30 D):	2.32M
Avg Daily Volume (90 D):	1.94M

Trade Size
Avg Trade Size (Sh.):	140
Avg Trade Size (Sh.) (30 D):	165
Avg Trade Size (Sh.) (90 D):	136

Institutional Trades
Total Institutional Trades:	287
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$1.66M
Avg Institutional Trade (90 D):	$1.17M
Avg Institutional Trade Volume:	.25M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.43M
Avg Closing Trade (30 D):	$1.91M
Avg Closing Trade (90 D):	$1.1M
Avg Closing Volume:	274.84K

News

Jul 7, 2026 @ 10:04 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Feb 26, 2026 @ 1:59 AM Larimar Therapeutics Announces Pricing of Upsized ... Source: Globe Newswire

Feb 26, 2026 @ 1:59 AM Larimar Therapeutics Announces Pricing of Upsized ... Source: Na

Oct 16, 2025 @ 8:44 AM Larimar Therapeutics, Inc. Investigated for Securi... Source: Prnewswire

Oct 16, 2025 @ 1:30 AM Larimar Therapeutics, Inc. Investigated for Securi... Source: Business Wire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS
Diluted EPS
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-29.61M	$-62.5M	$-165.67M
Operating Income / Loss	$-31.12M	$-64.02M	$-172.5M
Cost of Revenue
Net Cash Flow	$92.5M		$52.19M
PE Ratio